-
Xinlitai new drug xisataxing obtained clinical approval
Time of Update: 2020-04-03
The original research drug of sitafloxacin is developed by No.1 Pharmaceutical Co., Ltd., which belongs to broad-spectrum quinolones.
-
Diatom mud purchase: living in "yellow" all day diatom mud wall gives you different pleasure
Time of Update: 2020-04-03
When the indoor air is relatively dry, the wall of diatom mud will absorb the water Paint Home News: in home design, yellow is a pleasant and inspiring color.
-
Moxifloxacin, a new chemical drug of class 3.1 applied for production by new Hecheng, has been accepted
Time of Update: 2020-04-03
This application is a raw material drug, and the company obtained the clinical approval document in October last year.
-
Coating classification: interior wall anion bactericidal putty
Time of Update: 2020-04-03
Core tip: Introduction: the interior wall negative ion bactericidal putty has excellent physical and chemical properties, environmental protection, no pollution, alkali and water resistance, strong adhesion, good leveling, and is a new type of putty product with excellent performance.
-
Science: Fudan University and Harvard Medical School develop adjuvant of broad-spectrum influenza vaccine
Time of Update: 2020-02-22
February 22, 2020 ifn-is is the main immune mediator of protective immunity, which can effectively fight against infection; it can be activated by alveolar epithelial cells (AECs
-
Novel coronavirus pneumonia is a potential effective drug, and the sea is being approved by the public
Time of Update: 2020-02-17
Zhejiang Haizheng issued a notice that it received the approval of drug registration and approval of clinical trial of faveravir tablets (also known as fapiravir tablets) approved
-
The new "broad-spectrum anticancer drugs" aim at tumor metabolizing immunotherapy! Clinical trials are on the way
Time of Update: 2019-11-21
In different cancer models, jhu083 can change tumor cell metabolism and tumor microenvironment, prevent tumor growth and improve survival rate.
-
Kangenbei group: to become the largest CBD extract supplier in China
Time of Update: 2019-08-16
The first phase aims to become the largest CBD extract supplier in China and even in the world.
-
Progress in the field of portable plasmon biosensors by Zhang Weihua and Lu Zhenda of Nanjing University
Time of Update: 2019-06-26
In order to break the above limitation, Professor Zhang Weihua's research group and Professor Lu Zhenda's research group of College of modern engineering and Applied Sciences of Nanjing University have developed a kind of patterned plasmonic gradient (PPG).
-
The R & D cost is about 7.3 million yuan, and Kelun pharmaceutical is the first to pass the consistency evaluation
Time of Update: 2019-04-11
Up to now, according to the announcement, Kelun pharmaceutical has invested about 7.3 million yuan in the consistency evaluation project of Cefalexin Capsules.
-
Professor Xie Yongshu from East China University of science and technology made new progress in the research of porphyrin dye-sensitized solar cells
Time of Update: 2019-01-22
The relevant research results are entitled "efficient solar cells sensitized by a promising new type of porphyrins: Dye aggregation suppressed by double strapping" Published in Chemical Science (DOI: 10.1039 / c8sc04969f), a famous international chemical journal.
-
Puliconazole of puliconazole
Time of Update: 2018-12-03
On December 3, Puli pharmaceutical announced that voriconazole (200mg) for injection manufactured by the company had passed the FDA's listing approval and was qualified for sale in the United States.
-
Puliconazole of puliconazole has been listed on the market. The United States has agreed, and China has been undertaken
Time of Update: 2018-12-03
On December 3, Puli pharmaceutical announced that voriconazole (200mg) for injection manufactured by the company had passed the FDA's listing approval and was qualified for sale in the United States.
-
Preparation of new carbon nanomaterials: SP3 hybrid bonded carbon nitride nanowires
Time of Update: 2018-04-11
badding of the school of chemistry of Pennsylvania State University has prepared ordered carbon nitride nanowires with SP 3 hybrid orbital bonding using pyridine as raw material.
-
"Mitoxantrone Hydrochloride liposome" of Shijiazhuang Pharmaceutical Group has obtained FDA orphan drug qualification certification
Time of Update: 2017-09-29
Source: Medical Rubik's cube data on September 27, 2017, stone Pharmaceutical Group announced that FDA granted its orphan drug qualification of Mitoxantrone Hydrochloride liposome in the treatment of peripheral T-cell lymphoma (PTCL).
-
Approved clinical antitumor drugs of Kelun pharmaceutical holding subsidiary
Time of Update: 2017-07-11
Kl070002 is expected to provide more drug options for the treatment of high-risk cancer in China, such as lung cancer, colorectal cancer, pancreatic cancer, liver cancer and so on, with great clinical value.
-
Discussion on ultrasonic wave of ultrasonic extractor from different angles
Time of Update: 2015-01-22
In terms of power range of ultrasonic extractor, the continuous wave ultrasound is generally in the range of milliwatts to tens of kilowatts.
-
How to connect biopesticides with the big market
Time of Update: 2011-05-09
Now is the season when fruits and vegetables are on the market in large quantities
When people enjoy delicious food, they will inevitably have a layer of worries
-
Australian researchers found new chlorophyll
Time of Update: 2010-08-23
Researchers from the school of life sciences at the University of Sydney announced Tuesday that they have discovered a new type of chlorophyll, which is expected to have broad application prospects in the field of bioenergy.
-
New additives developed by Harbin Institute of Technology
Time of Update: 2008-11-03
The project "pilot study on the preparation of rare earth organic chromium feed additive by biological method", which was developed by Harbin University of technology, has passed the appraisal of the Provincial Department of science and technology.
